GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.7347
+0.0347 (4.96%)
At close: Dec 18, 2025, 4:00 PM EST
0.7450
+0.0103 (1.40%)
Pre-market: Dec 19, 2025, 9:08 AM EST
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $7.81 million as of December 19, 2025. Its market cap has increased by 24.04% in one year.
Market Cap
7.81M
Enterprise Value
5.29M
1-Year Change
24.04%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $7.81M, a decrease of -90.61%. That is a compound annual growth rate of -26.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 7.80M | 14.71% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |